Amniocentesis
அம்னியோசென்டெசிஸ்
Amniocentesis is a diagnostic tool, not a tool for social engineering. Misusing this procedure for sex determination is a criminal offense under the PCPNDT Act. Do not confuse the diagnostic utility with the legal prohibition in your exam.
The idea
Amniocentesis involves withdrawing a small sample of amniotic fluid surrounding the developing fetus. This fluid contains fetal cells, which are analyzed for chromosomal abnormalities like Down syndrome, hemophilia, and sickle-cell anemia. The procedure is strictly limited to detecting genetic disorders. Any use for sex determination is legally banned to prevent female foeticide.
Why it matters
Originally developed to detect chromosomal abnormalities and genetic defects in the developing fetus.
NEET lens
NEET asks this 8 times in the last decade. Focus on the purpose: 'Detection of genetic disorders'. Do not mark 'Sex determination' as a valid use in the exam. Remember, it is a prenatal diagnostic technique, not a screening for infectious diseases.
Clinical significance
When genetic screening fails or is ignored, children are born with severe, irreversible chromosomal disorders. Early detection via amniocentesis allows for prenatal counseling or management of conditions like Down syndrome. Without this, the burden of preventable genetic diseases remains high in the population.
Introduction
Amniocentesis is a prenatal diagnostic procedure in which amniotic fluid is sampled via a needle inserted through the mother's abdomen under ultrasound guidance (~15-20 weeks) to analyze fetal cells for chromosomal abnormalities (e.g., Down syndrome) and genetic disorders.
Core concept
Procedure: Ultrasound guidance → needle through maternal abdomen + uterine wall → amniotic cavity → ~15-20 mL fluid withdrawn. Timing: 15-20 weeks (earlier: transcervical chorionic villus sampling/CVS at 10-13 weeks). What's analyzed: Fetal cells in amniotic fluid → karyotyping (chromosomal disorders). Alpha-fetoprotein (AFP) levels (neural tube defects). Genetic analysis (PCR, microarray) for specific mutations. Amniotic fluid composition (fetal lung maturity). Detects: Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), Patau syndrome (trisomy 13), chromosomal deletions/duplications, neural tube defects (spina bifida, anencephaly), monogenic disorders (cystic fibrosis, sickle cell). Risks: 0.1-0.3% miscarriage risk. India: Amniocentesis for sex determination is BANNED under PCPNDT Act.
Go deeper
Chromosomal analysis from amniocentesis: fetal cells cultured → karyotype analysis. Newer: NIPT (Non-Invasive Prenatal Testing) — maternal blood sample → cell-free fetal DNA (from placenta) → chromosomal analysis → screens for trisomies 21, 18, 13. Non-invasive, from 10 weeks, but screening (not diagnostic) → abnormal result requires amniocentesis for confirmation.
From Class 10
Amniocentesis is a prenatal test in which a small sample of amniotic fluid (the fluid surrounding the fetus) is taken to check for chromosomal abnormalities and genetic disorders.